Prolonged response to metastatic pancreatic cancer treated with pembrolizumab based on mismatch repa

Prolonged response to metastatic pancreatic cancer treated with pembrolizumab based on mismatch repair status characterized from next generation sequencing

Lan Ngo

Summit_2021_poster_Lan_Ngo
.pdf
Download PDF • 789KB